Minimal data reporting standards for serological testing for histocompatibility.
暂无分享,去创建一个
L. Hidalgo | P. Jindra | A. Madbouly | S. Heidt | N. Valenzuela | A. Jackson | M. Askar | D. Pinelli | Abeer Madbouly
[1] C. Canter,et al. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] J. Friedewald,et al. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] N. Reinsmoen,et al. Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies. , 2017, Human immunology.
[4] Olivier Aubert,et al. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. , 2017, Journal of the American Society of Nephrology : JASN.
[5] G. Serban,et al. Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based Assays , 2017, Transplantation direct.
[6] A. Loupy,et al. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. , 2017, Kidney international.
[7] R. Bray,et al. The Road to HLA Antibody Evaluation: Do Not Rely on MFI , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] X. Jouven,et al. Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. , 2017, Journal of the American Society of Nephrology : JASN.
[9] A. Zeevi,et al. Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes , 2017, Front. Immunol..
[10] D. Min,et al. Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? , 2017, Journal of immunology research.
[11] C. Di Primo,et al. Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays. , 2016, Human immunology.
[12] M. Bots,et al. How can we reduce costs of solid‐phase multiplex‐bead assays used to determine anti‐HLA antibodies? , 2016, HLA.
[13] G. Pantaleo,et al. Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. , 2016, Human immunology.
[14] James Robinson,et al. Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing. , 2015, Human immunology.
[15] V. Sharma,et al. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure , 2015, Transplantation.
[16] J. Scoazec,et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.
[17] L. Kamal,et al. Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies , 2014, Transplantation.
[18] L. Sharples,et al. Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation. , 2014, Kidney international.
[19] C. Jacquelinet,et al. Denatured Class I Human Leukocyte Antigen Antibodies in Sensitized Kidney Recipients: Prevalence, Relevance, and Impact on Organ Allocation , 2014, Transplantation.
[20] R. Bray,et al. HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] P. Gourraud,et al. Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments. , 2014, Tissue antigens.
[22] J. Friedewald,et al. Epitope Analysis of HLA-DQ Antigens: What Does the Antibody See? , 2014, Transplantation.
[23] N. Maillard,et al. Solid‐Phase Bead‐Based Assays Limitations Are Not Restricted to Interlaboratory Variability , 2013, American Journal of Transplantation.
[24] P. Nickerson,et al. Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA‐Drilling Down on Key Sources of Variation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] Loren Gragert,et al. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. , 2013, Human immunology.
[26] X. Jouven,et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.
[27] M. Gandhi,et al. Lot‐to‐lot variability in HLA antibody screening using a multiplexed bead‐based assay , 2013, Transfusion.
[28] P S Heeger,et al. Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[29] C. Weinstock,et al. The complement‐mediated prozone effect in the Luminex single‐antigen bead assay and its impact on HLA antibody determination in patient sera , 2013, International journal of immunogenetics.
[30] A. Webster,et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.
[31] Greg Bennett,et al. High Transplant Rates of Highly Sensitized Recipients With Virtual Crossmatching in Kidney Paired Donation , 2012, Transplantation.
[32] M. González-Escribano,et al. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] S G E Marsh,et al. A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. , 2011, Tissue antigens.
[34] A. Ender,et al. HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.
[35] H. Wallerand,et al. Interpretation of Positive Flow Cytometric Crossmatch in the Era of the Single-Antigen Bead Assay , 2011, Transplantation.
[36] Dominique Charron,et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[37] T. Mohanakumar,et al. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. , 2010, Human immunology.
[38] G. Böhmig,et al. Clinical relevance of preformed C4d‐fixing and non‐C4d‐fixing HLA single antigen reactivity in renal allograft recipients , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[39] A. Zachary,et al. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. , 2009, Human immunology.
[40] P. Terasaki,et al. The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[41] J. Lunz,et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[42] P. Terasaki,et al. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens. , 2009, Clinical transplants.